These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8502347)

  • 1. [Current concepts on the alloreactive response].
    Lantz O; Alard P; Charpentier B
    Nephrologie; 1993; 14(1):3-7. PubMed ID: 8502347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogenic recognition in 1992.
    Lantz O; Alard P; Charpentier B
    Biomed Pharmacother; 1992; 46(2-3):85-90. PubMed ID: 1421042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes.
    Lombardi G; Lechler R
    Ann Ist Super Sanita; 1991; 27(1):7-14. PubMed ID: 1958030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC restriction and allogeneic immune responses.
    Kazansky DB
    J Immunotoxicol; 2008 Oct; 5(4):369-84. PubMed ID: 19404871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of allogenic recognition in transplantation systems].
    Fedoseeva EV
    Biokhimiia; 1995 Feb; 60(2):238-49. PubMed ID: 7718667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule.
    Reiser JB; Darnault C; Guimezanes A; Grégoire C; Mosser T; Schmitt-Verhulst AM; Fontecilla-Camps JC; Malissen B; Housset D; Mazza G
    Nat Immunol; 2000 Oct; 1(4):291-7. PubMed ID: 11017099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the MHC.
    Simpson E
    Immunol Suppl; 1988; 1():27-30. PubMed ID: 3133311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating peptide repertoires within the context of thymocyte development.
    Barton GM; Rudensky AY
    Semin Immunol; 1999 Dec; 11(6):417-22. PubMed ID: 10625595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative theory of affinity-driven T cell repertoire selection.
    Detours V; Mehr R; Perelson AS
    J Theor Biol; 1999 Oct; 200(4):389-403. PubMed ID: 10525398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant dimeric MHC antigens protect cardiac allografts from rejection and visualize alloreactive T cells.
    Fried A; Berg M; Sharma B; Bonde S; Zavazava N
    J Leukoc Biol; 2005 Sep; 78(3):595-604. PubMed ID: 16000395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell allorecognition and MHC restriction--A case of Jekyll and Hyde?
    Archbold JK; Ely LK; Kjer-Nielsen L; Burrows SR; Rossjohn J; McCluskey J; Macdonald WA
    Mol Immunol; 2008 Feb; 45(3):583-98. PubMed ID: 17869342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic selection does not limit the individual MHC diversity.
    Borghans JA; Noest AJ; De Boer RJ
    Eur J Immunol; 2003 Dec; 33(12):3353-8. PubMed ID: 14635043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on mechanisms of thymic selection by intrathymic administration of antigenic peptides].
    Nishihori H
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):517-28. PubMed ID: 9363468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunotherapeutic strategies using MHC derived peptides.
    Sayegh MH; Krensky AM
    Kidney Int Suppl; 1996 Jan; 53():S13-20. PubMed ID: 8770986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides.
    Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU
    J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.